在小腺瘤中增加PGE2和COX-2表达:对电解质耗尽综合征的影响
Shiki Fujino1,2, Hiroyuki Fukuda1, Katsuki Danno1
1Department of Surgery, Minoh City Hospital, Minoh, Osaka 562-0014, Japan.
Experimental and therapeutic medicine
|March 2, 2026
概括
前列腺素E2 (PGE2) 信号在小腺瘤 (VAs) 中升高,可能导致电解质耗尽综合征 (EDS). 这凸显了对VA的早期识别和向治疗的需要.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 结肠直肠小腺瘤 (VAs) 与管状腺瘤 (TAs) 相比,具有更高的恶性潜力和粘液分泌.
- 电解质枯竭综合征 (EDS) 是一种与结直肠腺瘤相关的罕见并发症.
研究的目的:
- 调查前列腺素E2 (PGE2) 信号在结肠直肠VA中EDS病变的作用.
- 为了比较VA和TA之间的PGE2和循环氧化酶 (COX) 异形表达.
主要方法:
- 对40个结直肠腺瘤病例 (20个VA,20个TA) 的回顾性分析.
- 对PGE2,COX-1和COX-2进行免疫组织化学染色.
- 对阳性腺体百分比的量化和对关联的统计分析.
主要成果:
- 与TA相比,VA在女性中更大,更常见.
- 在VA和TA中显著增加PGE2和COX-2表达.
- 在VA中,PGE2表达与COX-1和COX-2相关,但在TA中没有.
结论:
- 升级的PGE2信号可能会导致结直肠VAs中的EDS.
- 结果表明,与EDS相关的VA管理的潜在治疗目标.
- 早期识别具有高PGE2表达的VA至关重要.
相关概念视频
Peptic Ulcer Disease I: Introduction
940
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
940
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.4K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Peptic Ulcer Disease II: Pathophysiology
2.4K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.3K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.3K
Gastritis-II: Pathophysiology
1.5K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K


